FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Novartis Gets Full Approval for Tabrecta

[ Price : $8.95]

FDA grants full approval to Novartis for its previously accelerated-approved Tabrecta (capmatinib) for treating certain adult pati...

ClearPoint Neuro Brain Visualizer Cleared

[ Price : $8.95]

FDA clears a ClearPoint Neuro 510(k) for its ClearPoint Maestro Brain Model, software that uses MRI images to conduct labeling, vi...

FDA Updates Device Recognized Standards Listing

[ Price : $8.95]

Federal Register notice: FDA makes available a publication entitled Modifications to the List of Recognized Standards, Recognition...

FDA Working on Januvia Shortage

[ Price : $8.95]

FDA says it will temporarily allow distribution of some sitagliptin products with the nitrosamine impurity NTTP above acceptable i...

Comments on Radiolabeled Studies Draft

[ Price : $8.95]

Five stakeholders comment on an FDA draft guidance on radiolabeled mass balance studies.

FDA Clears ReShape Calibration Tubes

[ Price : $8.95]

FDA clears ReShape Lifesciences Gastro Intestinal Balloon Indicator calibration tube in three sizes.

Califf Combats Misinformation with 'Rumor Control' Page

[ Price : $8.95]

FDA and commissioner Robert Califf launch a new 'Rumor Control' Web page as part of the agency's first effort to address misinform...

Concerns About Drug Shortage Draft Guidance

[ Price : $8.95]

Two stakeholders raise concerns about an FDA draft guidance on risk management programs to mitigate drug shortage potential.

Change Buprenorphine Labeling: Petition

[ Price : $8.95]

The Colorado Society of Addiction Medicine says the labeling for buprenorphine products to treat opioid use disorder should be cha...

More Philips Cybersecurity Feedback

[ Price : $8.95]

Philips sends FDA additional comments on the agency discussion paper on strengthening cybersecurity practices for servicing medica...